[go: up one dir, main page]

MX2011008074A - Macrolido anti-inflamatorio. - Google Patents

Macrolido anti-inflamatorio.

Info

Publication number
MX2011008074A
MX2011008074A MX2011008074A MX2011008074A MX2011008074A MX 2011008074 A MX2011008074 A MX 2011008074A MX 2011008074 A MX2011008074 A MX 2011008074A MX 2011008074 A MX2011008074 A MX 2011008074A MX 2011008074 A MX2011008074 A MX 2011008074A
Authority
MX
Mexico
Prior art keywords
compound
macrolide
inflammatory
inflammatory macrolide
diethylaminoethanoyl
Prior art date
Application number
MX2011008074A
Other languages
English (en)
Inventor
Zorica Marusic-Istuk
Darko Filic
Leanda Jane Kindon
Caroline Jane Day
Julien Bruno Douillet
Goran Kragol
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41698466&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2011008074(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MX2011008074A publication Critical patent/MX2011008074A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

El compuesto 3'-N-desmetil-4"-O-(2-dietilaminoetanoil)-6-O- metil-9a-aza-9a-homoeritromicina A, que tiene la Fórmula (1) (ver fórmula (I)) o una sal del mismo, composiciones que comprenden el compuesto, su uso en el tratamiento de enfermedades inflamatorias dominadas por neutrófilos, y métodos para su preparación.
MX2011008074A 2009-01-30 2010-01-28 Macrolido anti-inflamatorio. MX2011008074A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14860909P 2009-01-30 2009-01-30
PCT/EP2010/050967 WO2010086349A1 (en) 2009-01-30 2010-01-28 Anti-inflammatory macrolide

Publications (1)

Publication Number Publication Date
MX2011008074A true MX2011008074A (es) 2011-08-17

Family

ID=41698466

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011008074A MX2011008074A (es) 2009-01-30 2010-01-28 Macrolido anti-inflamatorio.

Country Status (23)

Country Link
US (1) US8227428B2 (es)
EP (1) EP2384333B1 (es)
JP (1) JP5437394B2 (es)
KR (1) KR20110099791A (es)
CN (1) CN102378763A (es)
AR (1) AR075340A1 (es)
AU (1) AU2010209732B2 (es)
BR (1) BRPI1006114A2 (es)
CA (1) CA2748847A1 (es)
CL (1) CL2011001829A1 (es)
CO (1) CO6400226A2 (es)
DO (1) DOP2011000242A (es)
EA (1) EA201101139A1 (es)
ES (1) ES2412059T3 (es)
IL (1) IL213871A0 (es)
MA (1) MA32997B1 (es)
MX (1) MX2011008074A (es)
PE (1) PE20120220A1 (es)
SG (1) SG172782A1 (es)
TW (1) TW201038277A (es)
UY (1) UY32408A (es)
WO (1) WO2010086349A1 (es)
ZA (1) ZA201104653B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006087644A2 (en) 2005-01-13 2006-08-24 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Macrolides with anti-inflammatory activity
CA2748847A1 (en) 2009-01-30 2010-08-05 Glaxo Group Limited Anti-inflammatory macrolide
WO2011116312A1 (en) * 2010-03-19 2011-09-22 Catabasis Pharmaceuticals, Inc. Fatty acid macrolide derivatives and their uses
WO2011131749A1 (en) * 2010-04-23 2011-10-27 Glaxo Group Limited New 14 and 15 membered macrolides for the treatment of neutrophil dominated inflammatory diseases
JP6116206B2 (ja) * 2012-11-26 2017-04-19 クリニプロ株式会社 吸入用パウダーの製造方法
CA3049856C (en) * 2017-01-13 2021-10-26 Tobishi Pharmaceutical Co., Ltd. Neutrophil activation regulator
US20230137567A1 (en) 2020-03-12 2023-05-04 Zoetis Services Llc Immunomodulating trifluoromethyl-aminal azalides

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US525051A (en) 1894-08-28 Adjustable chair
US3725385A (en) 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
EP0126344A2 (en) 1983-05-20 1984-11-28 Abbott Laboratories Tripeptide esters of therapeutic agents
PT87417B (pt) * 1987-05-06 1992-08-31 Adir Processo para a preparacao de novos compostos macrolidos
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
EP0895999A1 (en) 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
HRP980189B1 (en) 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
CZ20014120A3 (cs) * 1999-05-18 2003-01-15 Pfizer Products Inc. Nové krystalické formy makrolidového antibiotika
HRP20010301A2 (en) 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
JP4790263B2 (ja) 2002-07-08 2011-10-12 グラクソ グループ リミテッド 炎症性の疾患および病態を治療する新規な化合物、組成物および方法
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
GB0310986D0 (en) 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
WO2006087644A2 (en) * 2005-01-13 2006-08-24 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Macrolides with anti-inflammatory activity
JP5036557B2 (ja) 2005-01-13 2012-09-26 グラクソ グループ リミテッド 抗炎症活性デクラジノシル−マクロライド
ES2371931T3 (es) 2005-01-14 2012-01-11 Glaxo Group Limited Compuestos macrólidos que contienen biotina y grupo con foto-afinidad para la identificación de la diana del macrólido.
CA2748847A1 (en) 2009-01-30 2010-08-05 Glaxo Group Limited Anti-inflammatory macrolide

Also Published As

Publication number Publication date
AR075340A1 (es) 2011-03-23
KR20110099791A (ko) 2011-09-08
CA2748847A1 (en) 2010-08-05
EA201101139A1 (ru) 2012-03-30
WO2010086349A1 (en) 2010-08-05
ES2412059T3 (es) 2013-07-10
DOP2011000242A (es) 2011-09-15
MA32997B1 (fr) 2012-01-02
UY32408A (es) 2010-07-30
ZA201104653B (en) 2012-02-29
PE20120220A1 (es) 2012-04-04
US20100197623A1 (en) 2010-08-05
IL213871A0 (en) 2011-07-31
CO6400226A2 (es) 2012-03-15
EP2384333B1 (en) 2013-04-17
JP2012516304A (ja) 2012-07-19
SG172782A1 (en) 2011-08-29
JP5437394B2 (ja) 2014-03-12
AU2010209732A1 (en) 2011-07-21
US8227428B2 (en) 2012-07-24
CN102378763A (zh) 2012-03-14
BRPI1006114A2 (pt) 2018-02-06
AU2010209732B2 (en) 2012-12-20
TW201038277A (en) 2010-11-01
CL2011001829A1 (es) 2011-10-14
EP2384333A1 (en) 2011-11-09

Similar Documents

Publication Publication Date Title
EA201101243A1 (ru) 3h-имидазо[4,5-c]пиридин-6-карбоксамиды в качестве противовоспалительных средств
PH12012500620A1 (en) Compounds
RS53617B1 (en) NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
MY171577A (en) 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication
MX2013004491A (es) Boronatos como inhibidores de arginasa.
MX2011008074A (es) Macrolido anti-inflamatorio.
PH12013500648A1 (en) Quinazolin-4 (3h) -one derivatives used as pi3 kinase inhibitors
NZ577916A (en) Cyclopamine analogs
RS52823B (en) NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
EP2090577A3 (en) Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors
HN2009000784A (es) Dihidropirazolonas sustituidas
MX2010001849A (es) Depsipeptidos ciclicos.
HRP20090017T3 (hr) 3,11b-cis-dihidrotetrabenazin za liječenje proliferativnog oboljenja ili upale
WO2015042414A8 (en) Multicyclic compounds and methods of using same
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
IL187001A0 (en) Preparation of (s)-4-fluromethyl-dihydro-furan -2-one
TW200640942A (en) New macrolides
EP1968606A4 (en) PREPARATION OF PHARMACEUTICAL SALTS OF 3-O- (3 ', 3'-DIMETHYLSUCCINYL) BETULINIC ACID
MX2011011618A (es) Agentes terapeuticos 713.
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
NZ591837A (en) Amino acid derivative
WO2012020021A9 (en) Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases
PH12013500027A1 (en) Therapeutic agents 976
ATE553088T1 (de) Substituierte chinolone ii
MX2015015682A (es) Uso de una tiazolo-pirimidinona para el tratamiento de enfermedad inflamatoria del instentino.

Legal Events

Date Code Title Description
FG Grant or registration